Flagship Pioneering, a venture capital firm investing in biomedical platform innovation, today announced ProFound Therapeutics, a new company that has identified thousands of previously unmapped human proteins, opening the door to a slew of novel therapeutic targets and therapies. The groundbreaking ProFoundry Platform™, which was founded at Flagship Labs in 2020, has spotted unique proteins, remapping the human genome landscape . . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge